Loading…
Blockchain Promotion Act of 2021
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Blockchain Promotion Act of 2021 This bill directs the Department of Commerce to establish the Blockchain Working Group to submit a report to Congress which contains a recommended definition of the distributed ledger technology commonly referred to as blockchain technology, and other specified recommendations regarding this technology.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · first_quarter · Health Issues
Prescription drug rebates in federal health programs Reform to the Centers for Medicare and Medicaid Innovation (CMMI) Inflation Reduction Act's changes to prescription drug pricing in Medicare H.R. 3353Contact Lens Prescription Verification Modernization Act (117th Congress) S. 1001 / H.R. 1843Telehealth Expansion Act H.R. 9160Healthcare Freedom Act (117th Congress) Pharmacy benefit manager (PBM) reform H.R. 3682Improving Transparency to Lower Drug Costs Act (117th Congress) Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act Enhanced PBM spread pricing transparency in Medicaid Enhanced specialty pharmacy reporting in Medicare Part D Reducing Medicare conflicts of interest in pharmacy and therapeutics (P&T) committees Biden administration proposal to expand Medicare price negotiation in FY 2024 budget S. 1644 / H.R. 3761Promising Pathway Act (117th Congress) Reforms to FDA review and approval Updates to Medicare reimbursement procedures for new drugs S. 1038 / H.R. 1613Drug Pricing Transparency in Medicaid Act H.R. 977Patient Access to Higher Quality Health Care Act of 2023 340B Program transparency and oversight H.R. 2679Pharmacy Benefits Manager Accountability Act Site-neutral payments in Medicare S. 1869 Site-based Invoicing and Transparency Enhancement (SITE) Act H.R.3799CHOICE Arrangement Act S. 2333Pandemic and All-Hazards Preparedness Act HR 4818Treat and Reduce Obesity Act S. 2254 / H.R 5385Medicare PBM Accountability Act HR 1843Telehealth Expansion Act H.R. 2880Protecting Patients Against PBM Abuses Act HR 2748Contact Lens Prescription Verification Modernization Act (117th Congress)
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
Prescription drug rebates in federal health programs Reform to the Centers for Medicare and Medicaid Innovation (CMMI) Inflation Reduction Act's changes to prescription drug pricing in Medicare H.R. 3353Contact Lens Prescription Verification Modernization Act (117th Congress) S. 1001 / H.R. 1843Telehealth Expansion Act H.R. 9160Healthcare Freedom Act (117th Congress) Pharmacy benefit manager (PBM) reform H.R. 3682Improving Transparency to Lower Drug Costs Act (117th Congress) Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act Enhanced PBM spread pricing transparency in Medicaid Enhanced specialty pharmacy reporting in Medicare Part D Reducing Medicare conflicts of interest in pharmacy and therapeutics (P&T) committees Biden administration proposal to expand Medicare price negotiation in FY 2024 budget S. 1644 / H.R. 3761Promising Pathway Act (117th Congress) Reforms to FDA review and approval Updates to Medicare reimbursement procedures for new drugs S. 1038 / H.R. 1613Drug Pricing Transparency in Medicaid Act H.R. 977Patient Access to Higher Quality Health Care Act of 2023 340B Program transparency and oversight H.R. 2679Pharmacy Benefits Manager Accountability Act Site-neutral payments in Medicare S. 1869 Site-based Invoicing and Transparency Enhancement (SITE) Act H.R.3799CHOICE Arrangement Act S. 2333Pandemic and All-Hazards Preparedness Act HR 4818Treat and Reduce Obesity Act S. 2254 / H.R 5385Medicare PBM Accountability Act HR 1843Telehealth Expansion Act H.R. 2880Protecting Patients Against PBM Abuses Act
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
Prescription drug rebates in federal health programs Reform to the Centers for Medicare and Medicaid Innovation (CMMI) Inflation Reduction Act's changes to prescription drug pricing in Medicare H.R. 3353Contact Lens Prescription Verification Modernization Act (117th Congress) S. 1001 / H.R. 1843Telehealth Expansion Act H.R. 9160Healthcare Freedom Act (117th Congress) Pharmacy benefit manager (PBM) reform H.R. 3682Improving Transparency to Lower Drug Costs Act (117th Congress) Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act Enhanced PBM spread pricing transparency in Medicaid Enhanced specialty pharmacy reporting in Medicare Part D Reducing Medicare conflicts of interest in pharmacy and therapeutics (P&T) committees Biden administration proposal to expand Medicare price negotiation in FY 2024 budget S. 1644 / H.R. 3761Promising Pathway Act (117th Congress) Reforms to FDA review and approval Updates to Medicare reimbursement procedures for new drugs S. 1038 / H.R. 1613Drug Pricing Transparency in Medicaid Act H.R. 977Patient Access to Higher Quality Health Care Act of 2023 340B Program transparency and oversight H.R. 2679Pharmacy Benefits Manager Accountability Act Site-neutral payments in Medicare S. 1869 Site-based Invoicing and Transparency Enhancement (SITE) Act H.R.3799CHOICE Arrangement Act S. 2333Pandemic and All-Hazards Preparedness Act HR 4818Treat and Reduce Obesity Act
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, star ratings, extreme and uncontrollable circumstances policy, normalization factors, stars contract consolidation) Mental Health and Substance Use (42 CFR Part 2) Medicaid Managed Care Medicare Site Neutrality Site-based Invoicing and Transparency Enhancement (SITE) Act (S.1869) Protecting Health Care for All Patients (PATIENTS) Act of 2022 (H.R. 7634) Medicaid Actuarial Soundness Pharmacy Benefit Manager (PBM) Operations and Practices, Spread Pricing Social Determinants of Health (SDOH) Health Equity/Health Disparities Maternal health (Medicaid postpartum coverage extension, Black Maternal Health) Medicare Savings Program (MSP) in Medicaid H.R. 7997, Increasing Medicare Advantage Benchmark Rates in Puerto Rico and other regions with low Medicare fee-for-service penetration and to make the Medicare Savings Program available in all jurisdictions Medicaid funding for Puerto Rico H.R. 2217 (Territory Federal Matching Requirement Equity Act of 2021) H.R. 1825 (A Bill to Remove the Matching Requirement for Medicare Part D Drugs) H.R. 1826 (Fairness in Medicare Part B Enrollment Act) S. 3778 (Territories Medicare Prescription Drug Assistance Equity Act of 2022) Medicare Part B penalties (H.R. 4027) Medicare Advantage reimbursement (H.R. 4411) Medicare Savings Program (H.R. 4410) Medicaid Eligibility and Renewals Medicare Advantage Supplemental Benefits Mental Health Parity 2024 Notice of Benefit and Payment Parameters CY2024 Medicare Advantage Advance Notice and Part D Program Medicaid and CHIP Managed Care Access, Finance, and Quality Proposed Rule Direct and Indirect Remuneration
Client expense: $1,430,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2023 · second_quarter · Health Issues
Legislative End of National Emergency (COVID-19) - H.J.Res.7, Public Law No: 118-3 Coverage of recommended preventative services -Affordable Care Acts (ACA) preventative services requirement, Braidwood v. Becerra ruling Pharmacy Benefit Manager (PBM) legislation including the PBM Reform Act - S. 1339 Safe Step Act - S. 652 Site-Based Invoicing and Transparency Enhancement (SITE) Act - S. 1869 Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023 - H.R. 3561 Transparent PRICE Act - H.R. 3281 Fairness for Patients Medications Act - H.R. 3285 Facilitating Accountability in Reimbursements Act (FAIR Act) - H.R. 3417 Chronic Disease Flexible Coverage Act - H.R. 3800 Mental Health Matters Act - (H.R. 7780) (117th Congress) Health Network and Directory Improvement Act - S. 5093 Healthcare Workforce Shortage - request for information (RFI), Senate Health, Education, Labor and Pensions (HELP) Committee Healthy Competition for Better Care Act - S. 3139 (118th Congress) Telehealth Expansion Act - S, 1001/H.R. 1843 HSA Telehealth Extension Telehealth Benefit Expansion for Workers Act - H.R. 824 Employer-sponsored health coverage Site-Neutral Payment Reform Hospital Billing Practices Mental health parity Health cost transparency Dependent Care Flexible Spending Accounts (FSAs) Health Flexible Spending Accounts (FSAs) Health Savings Accounts (HSAs) Chronic Disease Management Prescription drug legislation Surprise billing regulations Health Equity ERISA preemption Regulatory White House - End of Public Health Emergency (PHE) and National Emergency (NE) Department of Health (HHS), Department of Labor (Labor) and Department of Treasury (Treasury) - (the tri-agencies) - guidance issued on end of COVID-19 Public Health Emergency (PHE) and National Emergency (NE) Centers for Medicare and Medicaid Services (CMS) - comment letter underscoring importance of Medicare Advantage to employers and comments on 2024 rate notice HHS and CMS - request for information (RFI) - current essential health benefits guidance HHS, Labor and Treasury(the tri-agencies) - guidance on group health plan attestations to Gag clause prohibition HHS, Labor and Treasury(the tri-agencies) -clarification of air ambulance reporting deadline for group health plans HHS, Labor and Treasury(the tri-agencies) - prescription drug and health care cost reporting - submitted comments HHS, Labor and Treasury (the tri-agencies) - final surprise billing regulations on the independent dispute resolution (IDR) process HHS, Labor and Treasury (the tri-agencies) - request for information (RFI) - advanced explanation of benefits Treasury/IRS -Pre-Deductible Telehealth Care in High Deductible Health Plans HHS, Labor and Treasury (the tri-agencies) Mental health parity requirements for group health plans and insurers, including under the CAA HHS, Labor and Treasury (tri-agencies) - transparency provisions under the CAA HHS - Enforcement of Hospital Price Transparency Rules Treasury/IRS - request for guidance on repurposing of welfare benefit fund assets ERISA uniformity High Deductible Health Plans (HDHPs) Health Savings Accounts (HSAs) State health care requirements affecting self-insured plans Abortion coverage and travel benefits in health plans Employer mandate ERISA Preemption Preventative care
Client expense: $440,980 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office